Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Plexin A2 ELISA Kit (AC3442)
Cat.#: ASET-2031
Specifications
Description Human Plexin A2 ELISA Kit allows for the in vitro quantitative determination of human Plexin A2 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.281 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.469-30 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1564 Porcine FGF19 ELISA Kit (AC2975) Quantitative inquiry ASET-2002 Human 160 kD Neurofilament Medium ELISA Kit (AC3413) Quantitative inquiry ASET-1362 Mouse Urocortin ELISA Kit (AC2773) Quantitative inquiry ASET-2094 Mouse VMAT2 ELISA Kit (AC3505) Quantitative inquiry ASET-2489 Rat EAAT1 ELISA Kit (AC3900) Quantitative inquiry ASET-2000 Human CHL1 ELISA Kit (AC3411) Quantitative inquiry ASET-1452 Mouse Cannabinoid Receptor II ELISA Kit (AC2863) Quantitative inquiry ASET-1220 Human CacyBP ELISA Kit (AC2631) Quantitative inquiry ASET-1607 Human Glutamine Synthetase ELISA Kit (AC3018) Quantitative inquiry ASET-2078 Rat CDNF ELISA Kit (AC3489) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket